Developing New Anti-Influenza Drugs

Scientists at Cure Lab, Inc., a biotechnology company based in Canton, Massachusetts, in collaboration with researchers at Boston University and Harvard Medical School have discovered a potential new target for the development of anti-influenza (flu) drugs, including those that may be effective against potentially pandemic influenza strains like H5N1.Their findings have been published in the journal Cell Cycle. [click link for full article]

More: continued here

Filed under: Bird Flu on August 20th, 2007